LF
IDXX icon

Lansforsakringar Fondforvaltning’s Idexx Laboratories IDXX Stock Holding History

Lansforsakringar Fondforvaltning’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$12.7M Sell
24,161
-1,766
-7% -$991K 0.06% 258
2026
Q1 		$14.6M Sell
25,927
-449
-2% -$288K 0.08% 212
2025
Q4 		$17.8M Sell
26,376
-83
-0.3% -$56.5K 0.09% 184
2025
Q3 		$16.9M Buy
26,459
+963
+4% +$585K 0.09% 193
2025
Q2 		$13.7M Sell
25,496
-1,545
-6% -$739K 0.08% 212
2025
Q1 		$11.4M Sell
27,041
-111
-0.4% -$48.2K 0.07% 245
2024
Q4 		$11.2M Buy
+27,152
New +$11.9M 0.06% 257

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Lansforsakringar Fondforvaltning's IDXX Position: Q2 2026 in Review

Lansforsakringar Fondforvaltning reduced its Idexx Laboratories (IDXX) stake by 6.8% in Q2 2026, selling an estimated $991K and leaving 24,161 shares worth $12.7M. The position accounts for 0.06% of the portfolio, ranked #258.

Lansforsakringar Fondforvaltning first reported a position in IDXX in Q4 2024 and has held it in 7 quarters since. The position peaked at $17.8M in Q4 2025. 1,306 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Lansforsakringar Fondforvaltning held 24,161 shares of Idexx Laboratories worth $12.7M as of Q2 2026.
  • Lansforsakringar Fondforvaltning sold 1,766 Idexx Laboratories shares in Q2 2026, an estimated $991K.
  • Idexx Laboratories made up 0.06% of Lansforsakringar Fondforvaltning's portfolio in Q2 2026, its #258 holding.
  • Lansforsakringar Fondforvaltning first reported a position in Idexx Laboratories in Q4 2024 and has held it in 7 quarters since.
  • Lansforsakringar Fondforvaltning's Idexx Laboratories position peaked at $17.8M in Q4 2025.
  • 1,306 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Lansforsakringar Fondforvaltning's 13F filing for Q2 2026, filed 13 Aug 2026.